HILLHOUSE INVESTMENT MANAGEMENT, LTD. purchased 14.1% of their position (555.55K shares) of ARRIVENT BIOPHARMA, INC. on the open market
Open‑market purchase worth $10.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/1/2024ACC: 0000902664-24-000903
10% Owner
Since Dec 2025
-55.28M
Net shares
Net seller
$10.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
4.48M acquired · 59.76M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+3.62M
Price / share
—
Trade value
—
% of position
New position
1/30/2024
0.00→3.62M
Common Stock
Indirect
Shares
+313.08K
Price / share
—
Trade value
—
% of position
8.7%
1/30/2024
3.62M→3.93M
Common Stock
Indirect
Shares
+555.55K
Price / share
$18.00
Trade value
$10M
% of position
14.1%
1/30/2024
3.93M→4.48M
Total
Net shares
+4.48M
Net value
$10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/30/2024 | C · Conversion | +3.62M | — | — | New position | 0.00 | 3.62M |
| Common Stock Indirect | 1/30/2024 | C · Conversion | +313.08K | — | — | 8.7% | 3.62M | 3.93M |
| Common Stock Indirect | 1/30/2024 | P · Purchase | +555.55K | $18.00 | $10M | 14.1% | 3.93M | 4.48M |
| Total | +4.48M | $10M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
3.62M shares
Shares
−55M
Strike price
Held after
0.00
Exercisable
—
1/30/2024
Series B Preferred Stock
Indirect
Converts to
Common Stock
313.08K shares
Shares
−4.76M
Strike price
Held after
0.00
Exercisable
—
1/30/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock3.62M shares | 1/30/2024 | C · Conversion | −55M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock313.08K shares | 1/30/2024 | C · Conversion | −4.76M | — | 0.00 |